An integrated approach to biologics R&D
Incyte develops a wide range of therapeutics, primarily for oncology. Benchling supports their antibody discovery group.
|Lack of a central informatics solution|
Incyte’s antibody discovery group was starting from the ground-up and knew it would be pivotal to deploy a world-class informatics system as soon as possible.
|Difficulty in tracking experimental results and progress|
With a growing team and fluid processes, the antibody discovery group needed a flexible system, or else their data would be unreliable and difficult to track.
|Collaborating across intercontinental sites without a shared system|
Being able to work with external collaborators (including international collaborators) was a must.
|Tracking constructs and components|
Benchling’s ability to automatically identify and register scFvs’ components makes it easy to track constructs.
|Secure data for collaborations|
With Benchling’s rich data permissions, Incyte can extend the system to its external collaborators, streamlining secure data transfer.
|Data clarity from the start|
Since the start of their operations, the antibody discovery group has gotten visibility into their key processes.